Meta Analysis to Compare Overall Survival Between Primary Metastatic Breast Cancer and Recurrent Metastatic Breast Cancer

被引：0
|
作者：
Aseyev, O. [1 ]
Alanbagi, A. [1 ]
机构：
[1] Dnepropetrovsk State Med Acad, Dnepropetrovsk, Ukraine
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [1] Disease progression as a predictor of overall survival in metastatic breast cancer: a meta-analysis
    Sherrill, B.
    Amonkar, M.
    Wu, Y.
    Hirst, C.
    Stein, S.
    Walkers, M.
    Cuzick, J.
    EJC SUPPLEMENTS, 2008, 6 (07): : 216 - 216
  • [2] A COMPARISON BETWEEN INITIALLY METASTATIC BREAST CANCER (IMBC) AND RECURRENT METASTATIC BREAST CANCER (RBC)
    Yoshida, Miwa
    Shimizu, Chikako
    Kouno, Tsutomu
    Katsumata, Noriyuki
    Andou, Masashi
    Tamura, Kenji
    Fujiwara, Yasuhiro
    ANNALS OF ONCOLOGY, 2010, 21 : 21 - 21
  • [3] Survival after primary metastatic breast cancer
    Jansen, Lina
    Hermann, Silke
    Bergbold, Susanne
    Holleczek, Bernd
    Heil, Joerg
    Kraywinkel, Klaus
    Arndt, Volker
    ONKOLOGE, 2020, 26 (06): : 487 - 496
  • [4] Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
    Villacampa, Guillermo
    Papakonstantinou, Andri
    Fredriksson, Irma
    Matikas, Alexios
    ONCOLOGIST, 2024, 29 (01): : 1 - 7
  • [5] Discordance in receptor status between primary and metastatic breast cancer and overall survival: A single-center analysis
    Mellouli, Manel
    Graja, Soumaya
    Ben Kridis, Wala
    Ben Ayed, Houda
    Makni, Saadia
    Triki, Meriam
    Charfi, Slim
    Khanfir, Afef
    Boudawara, Tahya Sellami
    Kallel, Rim
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 61
  • [6] PRIMARY TUMOR SURGERY IN METASTATIC BREAST CANCER: SURVIVAL ANALYSIS
    Lizana Guillermo, Fernandez
    Ibanez Blanca, Gil
    De La Fuente Joana, Izquierdo
    Nuno Beatrice, Conti
    Parra Laura, Beltran
    Maria Consuelo, Sanz Ferrandez
    Sanchez Sofia, Aragon
    Valiente Laura, Alvaro
    ANTICANCER RESEARCH, 2023, 43 (07) : 3380 - 3381
  • [7] Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    D J A Lobbezoo
    R J W van Kampen
    A C Voogd
    M W Dercksen
    F van den Berkmortel
    T J Smilde
    A J van de Wouw
    F P J Peters
    J M G H van Riel
    N A J B Peters
    M de Boer
    P G M Peer
    V C G Tjan-Heijnen
    British Journal of Cancer, 2015, 112 : 1445 - 1451
  • [8] Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    Lobbezoo, D. J. A.
    van Kampen, R. J. W.
    Voogd, A. C.
    Dercksen, M. W.
    van den Berkmortel, F.
    Smilde, T. J.
    van de Wouw, A. J.
    Peters, F. P. J.
    van Riel, J. M. G. H.
    Peters, N. A. J. B.
    de Boer, M.
    Peer, P. G. M.
    Tjan-Heijnen, V. C. G.
    BRITISH JOURNAL OF CANCER, 2015, 112 (09) : 1445 - 1451
  • [9] Prognosis of metastatic breast cancer: Differences between patients with de novo and recurrent metastatic breast cancer
    Tjan-Heijnen, V. C. G.
    Lobbezoo, D. J. A.
    van Kampen, R. J. W.
    Dercksen, M. W.
    Voogd, A. C.
    van den Berkmortel, F.
    Smilde, T. J.
    van de Wouw, A. J.
    van Riels, J. M. G. H.
    Peters, N. A. J. B.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S72 - S73
  • [10] Association between bisphosphonate use in metastatic breast cancer (MBC) and overall survival
    Mathew, A.
    Rosenzweig, M. Q.
    Brufsky, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
12345